Annals of Allergy Asthma & Immunology最新文献

筛选
英文 中文
Evaluation of the PEN-FAST clinical decision rule in non–beta-lactam antibiotic allergy assessment PEN-FAST临床决策准则在非β -内酰胺类抗生素过敏评价中的应用
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.06.019
Deniz Göcebe MD , Elham Khatamzas MD , Alexander Enk MD , Knut Schäkel MD
{"title":"Evaluation of the PEN-FAST clinical decision rule in non–beta-lactam antibiotic allergy assessment","authors":"Deniz Göcebe MD ,&nbsp;Elham Khatamzas MD ,&nbsp;Alexander Enk MD ,&nbsp;Knut Schäkel MD","doi":"10.1016/j.anai.2025.06.019","DOIUrl":"10.1016/j.anai.2025.06.019","url":null,"abstract":"<div><h3>Background</h3><div>False antibiotic allergy labels lead to the unnecessary use of broad-spectrum agents, contributing to antimicrobial resistance and poorer clinical outcomes. Penicillin allergy delabeling initiatives have been supported by validated clinical decision rules such as PEN-FAST. However, there are currently no available standardized approaches for non–beta-lactam allergies, for which standardized and validated skin tests are also lacking.</div></div><div><h3>Objective</h3><div>First, to validate the safety and negative predictive value (NPV) of PEN-FAST for penicillin allergies. Second, to evaluate whether the performance of PEN-FAST could be replicated for non–beta-lactam antibiotic allergy labels.</div></div><div><h3>Methods</h3><div>This retrospective single-center comparative cohort study analyzed adult patients with penicillin or non–beta-lactam allergy labels referred to our allergy division at the Department of Dermatology, Heidelberg, Germany. Allergy assessment included skin tests and subsequent drug challenge. The performance of the previously published PEN-FAST criteria was evaluated for both cohorts.</div></div><div><h3>Results</h3><div>A total of 102 penicillin allergy and 191 non–beta-lactam labels were analyzed. Confirmed allergies were more prevalent among non–beta-lactams (50.3% vs 37.3%). PEN-FAST exhibited high sensitivity for both penicillin (97.4%) and non–beta-lactams (94.8%), with an NPV of 95.8% and 82.8%, respectively. Misclassifications were limited to mild cutaneous reactions. Excluding clindamycin labels increased the NPV for non–beta-lactams to 95%.</div></div><div><h3>Conclusion</h3><div>Despite lower NPV for non–beta-lactam labels and varying performance across antibiotic classes, our results indicate that PEN-FAST may serve as a safe risk stratification tool for non–beta-lactam allergy labels. Prospective studies with direct drug challenges are required to assess its utility in the delabeling of non–beta-lactam allergies.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 443-447.e3"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144477740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moving closer toward personalized management of drug allergy 向药物过敏的个性化管理迈进了一步
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.08.002
Anna Nowak-Wegrzyn MD, PhD , Francesca Levi-Schaffer PharmD, PhD, FRCP Hon
{"title":"Moving closer toward personalized management of drug allergy","authors":"Anna Nowak-Wegrzyn MD, PhD ,&nbsp;Francesca Levi-Schaffer PharmD, PhD, FRCP Hon","doi":"10.1016/j.anai.2025.08.002","DOIUrl":"10.1016/j.anai.2025.08.002","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 355-356"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145183793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and phenotype of food allergy in children with cystic fibrosis 囊性纤维化儿童食物过敏的患病率和表型。
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.06.024
Hang P. Nguyen BS , Veronika Shabanova PhD , Sarah McCollum MPH , Brooke Polk MD , Tricia Lee MD , Kyle Whittington MD , Priscila Cunha MD , Emanuela M. Bruscia PhD , Marie E. Egan MD , Marc Emmenegger PhD , Stephanie Leeds MD, MHS
{"title":"Prevalence and phenotype of food allergy in children with cystic fibrosis","authors":"Hang P. Nguyen BS ,&nbsp;Veronika Shabanova PhD ,&nbsp;Sarah McCollum MPH ,&nbsp;Brooke Polk MD ,&nbsp;Tricia Lee MD ,&nbsp;Kyle Whittington MD ,&nbsp;Priscila Cunha MD ,&nbsp;Emanuela M. Bruscia PhD ,&nbsp;Marie E. Egan MD ,&nbsp;Marc Emmenegger PhD ,&nbsp;Stephanie Leeds MD, MHS","doi":"10.1016/j.anai.2025.06.024","DOIUrl":"10.1016/j.anai.2025.06.024","url":null,"abstract":"<div><h3>Background</h3><div>Nonspecific gastrointestinal symptoms associated with cystic fibrosis (CF) may be misdiagnosed as food allergy (FA). There is a paucity of data regarding the prevalence and phenotype of IgE–mediated FA in CF.</div></div><div><h3>Objective</h3><div>To determine the prevalence and characteristics of pediatric FA in CF.</div></div><div><h3>Methods</h3><div>We conducted a retrospective pediatric cohort study using the CF foundation registries and electronic medical records from (redacted names A and B). Demographic, biometric, and medical information were collected, and individuals suspected of having FA were identified through multiple inclusion criteria. A convincing FA diagnosis was established on the basis of a priori criteria, including medical history, testing results, and management. The estimated prevalence was calculated as a percentage and compared with the most recently reported pediatric FA prevalence in the United States.</div></div><div><h3>Results</h3><div>Among 289 patients (51.21% male sex, median age = 12.40 years), 11 (3.81%, 95% CI 1.91-6.71) had at least 1 convincing FA, yielding a smaller prevalence than the most recent estimate in the US pediatric population (7.60%, 95% CI 7.10-8.10, <em>P</em> = .015). Male patients with CF (6.08% vs 1.42%, <em>P</em> = .038) and patients without pancreatic enzyme replacement (9.09% vs 2.25%, <em>P</em> = .020) had a higher prevalence of convincing FA.</div></div><div><h3>Conclusion</h3><div>Our study of pediatric patients with CF found a lower prevalence of FA compared with the general pediatric population in the United States. Stringent criteria should be used when labeling patients with CF who have FA to minimize overdiagnosis. Further studies are needed to investigate whether CF could potentially be protective against the development of FA.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 419-424"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144477743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type 2 biomarkers and airway hyper-responsiveness disconnect in patients with uncontrolled severe asthma taking benralizumab or dupilumab 2型生物标志物和气道高反应性在服用benralizumab或dupilumab的未控制的严重哮喘患者中断开。
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.07.024
Robert Greig MbChB, Rory Chan PhD, Brian Lipworth MD
{"title":"Type 2 biomarkers and airway hyper-responsiveness disconnect in patients with uncontrolled severe asthma taking benralizumab or dupilumab","authors":"Robert Greig MbChB,&nbsp;Rory Chan PhD,&nbsp;Brian Lipworth MD","doi":"10.1016/j.anai.2025.07.024","DOIUrl":"10.1016/j.anai.2025.07.024","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 448-449"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144735097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dupilumab efficacy in relation to changes in club cell secretory protein 16 Dupilumab疗效与俱乐部细胞分泌蛋白变化的关系
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.05.027
Hao-Yun Chen MD , Yi-Hsuan Tu MD , Yun-Cheng Tsai MD , Su-Boon Yong MD, PhD , Chin-Yuan Yii MD
{"title":"Dupilumab efficacy in relation to changes in club cell secretory protein 16","authors":"Hao-Yun Chen MD ,&nbsp;Yi-Hsuan Tu MD ,&nbsp;Yun-Cheng Tsai MD ,&nbsp;Su-Boon Yong MD, PhD ,&nbsp;Chin-Yuan Yii MD","doi":"10.1016/j.anai.2025.05.027","DOIUrl":"10.1016/j.anai.2025.05.027","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 458-459"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145183848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
10 ways to improve emergency preparedness for patients with allergy while flying 10种方法提高飞机过敏患者的应急准备。
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.06.025
Sangeetha M. Kodoth MD , Niraj C. Patel MD, MS , Hyun J. Park MD, PhD , Joel P. Brooks DO, MPH
{"title":"10 ways to improve emergency preparedness for patients with allergy while flying","authors":"Sangeetha M. Kodoth MD ,&nbsp;Niraj C. Patel MD, MS ,&nbsp;Hyun J. Park MD, PhD ,&nbsp;Joel P. Brooks DO, MPH","doi":"10.1016/j.anai.2025.06.025","DOIUrl":"10.1016/j.anai.2025.06.025","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 464-465"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe asthma and new-onset meat allergy in a child: Could a new puppy be to blame? 儿童出现严重哮喘和新出现的肉类过敏——新养的小狗是罪魁祸首吗?
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.06.033
Gauri Misra MD , Rebecca Grohman DO , Mikhail Kazachkov MD , Anna Nowak-Wegrzyn MD, PhD
{"title":"Severe asthma and new-onset meat allergy in a child: Could a new puppy be to blame?","authors":"Gauri Misra MD ,&nbsp;Rebecca Grohman DO ,&nbsp;Mikhail Kazachkov MD ,&nbsp;Anna Nowak-Wegrzyn MD, PhD","doi":"10.1016/j.anai.2025.06.033","DOIUrl":"10.1016/j.anai.2025.06.033","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 363-365"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144565445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corticosteroid stewardship 皮质类固醇管理
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.07.026
Stanley J. Szefler MD
{"title":"Corticosteroid stewardship","authors":"Stanley J. Szefler MD","doi":"10.1016/j.anai.2025.07.026","DOIUrl":"10.1016/j.anai.2025.07.026","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 359-360"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145183794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Birch! 白桦!
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.05.014
Erin L. Reigh MD, MS
{"title":"Birch!","authors":"Erin L. Reigh MD, MS","doi":"10.1016/j.anai.2025.05.014","DOIUrl":"10.1016/j.anai.2025.05.014","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 383-384"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145183795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of remote therapeutic monitoring to increase inhaled corticosteroid adherence in children with high-risk asthma 远程患者监测提高高危哮喘患儿吸入性皮质类固醇依从性的可行性
IF 4.7 2区 医学
Annals of Allergy Asthma & Immunology Pub Date : 2025-10-01 DOI: 10.1016/j.anai.2025.07.016
Linda E. Mendoza DNP, CPNP, AE-C , Clarisse G. Casilang MD , Tricia Morphew MS , Jennifer Barrows PhD, RN , Paulina Schuhler MSN, RN , Stanley P. Galant MD
{"title":"Feasibility of remote therapeutic monitoring to increase inhaled corticosteroid adherence in children with high-risk asthma","authors":"Linda E. Mendoza DNP, CPNP, AE-C ,&nbsp;Clarisse G. Casilang MD ,&nbsp;Tricia Morphew MS ,&nbsp;Jennifer Barrows PhD, RN ,&nbsp;Paulina Schuhler MSN, RN ,&nbsp;Stanley P. Galant MD","doi":"10.1016/j.anai.2025.07.016","DOIUrl":"10.1016/j.anai.2025.07.016","url":null,"abstract":"<div><h3>Background</h3><div>Asthma can be well-controlled with the use of inhaled corticosteroids (ICS), but most children and adolescents do not adhere to recommended treatment, leading to exacerbations, emergency department visits, hospitalizations, and deaths. Remote therapeutic monitoring (RTM) has demonstrated potential to increase ICS adherence and improve asthma outcomes, but few studies have been conducted in young people, and lack of research in minority groups may contribute to health disparities.</div></div><div><h3>Objective</h3><div>To evaluate the feasibility of RTM in children and adolescents who receive asthma care at an urban mobile clinic serving a predominantly Hispanic population.</div></div><div><h3>Methods</h3><div>A total of 20 children aged 5 to 17 years participated in RTM for 6 months. Feasibility evaluation included recruitment, retention, implementation factors, and participant and provider satisfaction. ICS adherence and asthma-related outcomes were assessed monthly and analyzed descriptively.</div></div><div><h3>Results</h3><div>Of 24 eligible participants, 20 (83%) were recruited and 19 (95%) completed the study. Participants found RTM satisfactory with a mean rating of 4.6 of 5. Although some encountered practical challenges, 10 of 14 respondents (71%) indicated that they would continue using RTM. Providers rated their satisfaction 4 of 5, but RTM did not consistently meet patient needs, nor was it well-integrated with their workflow. Overall mean ICS adherence was 53%, and patients requiring emergency department visits decreased from 10 at baseline to 5 during the intervention.</div></div><div><h3>Conclusion</h3><div>RTM is feasible in underserved children with asthma, but implementation requires additional support from clinical staff. Further research is needed to determine efficacy.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"135 4","pages":"Pages 393-402"},"PeriodicalIF":4.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信